U.S., Dec. 24 -- An application to own the trademark for 'ROIVANT' has been filed on Apr. 04, 2025.
Owner(s):
Roivant Sciences GmbH; Viaduktstrasse 8, , SWITZERLAND
Goods and/or Services:
For: Pharmaceutical preparations for human use for the treatment of central nervous system, neurological, dementia, dermatological, metabolic, hematologic, infectious, auto-immune, immune deficiency, genetic, hepatological, cardiometabolic, urological, oncological, endocrine and endocrine-related, gynecological, ophthalmological, respiratory, cardiac, and pulmonary disorders, diseases and conditions
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2025-12-23&serialNumb...